SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-032984
Filing Date
2013-04-25
Accepted
2013-04-25 16:04:33
Documents
15
Period of Report
2013-04-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-10598_18k.htm 8-K 25958
2 EX-99.1 a13-10598_1ex99d1.htm EX-99.1 26782
3 EX-99.2 a13-10598_1ex99d2.htm EX-99.2 31004
4 GRAPHIC g105981mmi001.jpg GRAPHIC 2113
5 GRAPHIC g105981moi001.gif GRAPHIC 163301
6 GRAPHIC g105981moi002.jpg GRAPHIC 144208
7 GRAPHIC g105981moi003.gif GRAPHIC 140379
8 GRAPHIC g105981moi004.gif GRAPHIC 142219
9 GRAPHIC g105981moi005.jpg GRAPHIC 80311
10 GRAPHIC g105981moi006.gif GRAPHIC 73048
11 GRAPHIC g105981moi007.jpg GRAPHIC 91471
12 GRAPHIC g105981moi008.gif GRAPHIC 71229
13 GRAPHIC g105981moi009.gif GRAPHIC 70608
14 GRAPHIC g105981moi010.gif GRAPHIC 89540
15 GRAPHIC g105981moi011.gif GRAPHIC 159385
  Complete submission text file 0001104659-13-032984.txt   1778396
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 13782887
SIC: 2834 Pharmaceutical Preparations